Reveragen.com


Keyword Suggestion

Reveragen biopharma
Reveragen jobs
Reveragen biopharma careers



Domain Informations

Reveragen.com lookup results from whois.domain.com server:
  • Domain created: 2011-02-18T19:12:20Z
  • Domain updated: 2025-01-29T08:56:42Z
  • Domain expires: 2026-02-18T19:12:20Z 0 Years, 44 Days left
  • Website age: 14 Years, 321 Days
  • Registrar Domain ID: 1640928658_DOMAIN_COM-VRSN
  • Registrar Url: http://www.domain.com
  • Registrar WHOIS Server: whois.domain.com
  • Registrar Abuse Contact Email: [email protected]
  • Registrar Abuse Contact Phone: +1.8003337680
  • Name server:
    • NS1.BDM.MICROSOFTONLINE.COM
    • NS2.BDM.MICROSOFTONLINE.COM

Network
  • inetnum : 35.208.0.0 - 35.247.255.255
  • name : GOOGLE-CLOUD
  • handle : NET-35-208-0-0-1
  • status : Direct Allocation
  • created : 2006-09-29
  • changed : 2019-11-01
  • desc : *** The IP addresses under this Org-ID are in use by Google Cloud customers ***,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,*** The IP addresses under this Org-ID are in use by Google Cloud customers ***,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,Complaints sent to any other POC will be ignored.
Owner
  • organization : Google LLC
  • handle : GOOGL-2
  • address : Array,Mountain View,CA,94043,US
Technical support
Abuse
Domain Provider Number Of Domains
godaddy.com 286730
namecheap.com 101387
networksolutions.com 69118
tucows.com 52617
publicdomainregistry.com 39120
whois.godaddy.com 32793
enomdomains.com 23825
namesilo.com 21429
domains.google.com 21384
cloudflare.com 20573
gmo.jp 18110
name.com 17601
fastdomain.com 14708
register.com 13495
net.cn 12481
ionos.com 12416
ovh.com 12416
gandi.net 12305
registrar.amazon.com 12111


Host Informations

  • IP address: 35.212.86.52
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Check all domain's dns records


See Web Sites Hosted on 35.212.86.52

Fetching Web Sites Hosted


Site Inspections


Port Scanner (IP: 35.212.86.52)

 › Ftp: 21
 › Ssh: 22
 › Telnet: 23
 › Smtp: 25
 › Dns: 53
 › Http: 80
 › Pop3: 110
 › Portmapper, rpcbind: 111
 › Microsoft RPC services: 135
 › Netbios: 139
 › Imap: 143
 › Ldap: 389
 › Https: 443
 › SMB directly over IP: 445
 › Msa-outlook: 587
 › IIS, NFS, or listener RFS remote_file_sharing: 1025
 › Lotus notes: 1352
 › Sql server: 1433
 › Point-to-point tunnelling protocol: 1723
 › My sql: 3306
 › Remote desktop: 3389
 › Session Initiation Protocol (SIP): 5060
 › Virtual Network Computer display: 5900
 › X Window server: 6001
 › Webcache: 8080


Spam Check (IP: 35.212.86.52)

 › Dnsbl-1.uceprotect.net:
 › Dnsbl-2.uceprotect.net:
 › Dnsbl-3.uceprotect.net:
 › Dnsbl.dronebl.org:
 › Dnsbl.sorbs.net:
 › Spam.dnsbl.sorbs.net:
 › Bl.spamcop.net:
 › Recent.dnsbl.sorbs.net:
 › All.spamrats.com:
 › B.barracudacentral.org:
 › Bl.blocklist.de:
 › Bl.emailbasura.org:
 › Bl.mailspike.org:
 › Bl.spamcop.net:
 › Cblplus.anti-spam.org.cn:
 › Dnsbl.anticaptcha.net:
 › Ip.v4bl.org:
 › Fnrbl.fast.net:
 › Dnsrbl.swinog.ch:
 › Mail-abuse.blacklist.jippg.org:
 › Singlebl.spamgrouper.com:
 › Spam.abuse.ch:
 › Spamsources.fabel.dk:
 › Virbl.dnsbl.bit.nl:
 › Cbl.abuseat.org:
 › Dnsbl.justspam.org:
 › Zen.spamhaus.org:


Email address with reveragen.com

Found 1 emails of this domain
1. [email protected]

Recent Searched Sites

Climateinstitute.bmo.com (6 seconds ago) / US

Etnik.fr (2 seconds ago) / FR

Megaweb11at.com (4 seconds ago) / US

Psp.mariobrosonline.xyz (4 seconds ago) / LT

Dev.columbiasc.gov (17 seconds ago) / US

Marcotrabucco.com (9 seconds ago) / IT

Jobagri.com (1 seconds ago) / DE

Reveragen.com (1 seconds ago) / US

Himalayavillas.com (4 seconds ago) / US

Tapfood.vn (15 seconds ago) / VN

67.game (0 seconds ago) / US

Humanitas-spa.it (2 seconds ago) / US

Hoshino-cl.com (3 seconds ago) / JP

Hoodwinkconsulting.com (8 seconds ago) / US

Unclaimedassetmatching.com (5 seconds ago) / US

Fulltv.nl (11 seconds ago) / US

En.wlanjie.com (6 seconds ago) / US

Telegramfxcopier.io (9 seconds ago) / US

Tudoepoema.com.br (7 seconds ago) / US

Greenergagets.org (4 seconds ago) / US

Websites Listing

We found Websites Listing below when search with reveragen.com on Search Engine

Reveragen Biopharma, Inc. Company Profile | Rockville, MD

Company Description: Reveragen Biopharma, Inc. is located in Rockville, MD, United States and is part of the Scientific Research and Development Services Industry. Reveragen Biopharma, Inc. has 4 total employees across all of its locations and generates $894,075 in sales (USD). (Sales figure is modelled).

Dnb.com

ReveraGen BioPharma Inc - $4.4 Million Revenue | Kona Equity

Weaknesses. ReveraGen BioPharma Inc has a very small market share in their industry. Revenue generated per employee is less than the industry average. Revenue growth is less than the industry average. The number of employees is not growing as fast as the industry average. Variance of revenue growth is more than the industry average.

Konaequity.com

Reveragen Average Salaries | Salary.com

Reveragen pays an average salary of $4,478,996 and salaries range from a low of $3,926,435 to a high of $5,134,530. Individual salaries will, of course, vary depending on the job, department, location, as well as the individual skills and education of each employee. Avg. Base Salary (USD) $4,478,996 /year ...

Salary.com

ReveraGen: Receives $3.3 Million from National Institutes of Health ...

2020-11-17  · November 17, 2020. Research & Development. ReveraGen BioPharma, the developer of vamorolone, received a 3.3 million dollar grant from the National Institutes of Health (NIH) to support the commercialization of this safer alternative for corticosteroids treatment. This will advance vamorolone towards FDA submission and commercialization in the USA.

Defeatduchenne.ca

ReveraGen BioPharma Inc. - Company Profiles - BCIQ

For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the …

Biocentury.com

ReveraGen Receives $3.3 Million NIH Grant for NDA Preparations …

2020-11-17  · The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) has awarded a $3.3 million grant to ReveraGen Inc. to support the advancement of vamorolone towards FDA submission and commercialization.. The two-year Small Business Innovation Research (SBIR) / Small Business Technology Transfer (STTR) …

Parentprojectmd.org

Idorsia maintains collaboration agreement with ReveraGen

2018-11-05  · Allschwil, Switzerland - November 5, 2018. Idorsia Ltd (SIX: IDIA) today announced that it has maintained the collaborative agreement with ReveraGen to research and co-develop vamorolone, a non-hormonal steroid modulator currently investigated for the treatment of Duchenne Muscular Dystrophy (DMD). Following receipt of the clinical study report ...

Idorsia.com

Positive data with vamorolone in DMD - La Force dmd

2019-10-07  · These top-line data were presented on October 5 by Eric Hoffman, Ph.D., CEO of ReveraGen at the World Muscle Society (WMS) congress. In a late-breaking presentation at the WMS international conference in Copenhagen, Denmark, ReveraGen presented motor function and tolerability data from 23 DMD patients treated with 2.0 or 6.0 mg/kg/day with vamorolone …

Laforcedmd.com

US3842105A - Process for the preparation of 16,17-unsaturated …

US3842105A US00331060A US33106073A US3842105A US 3842105 A US3842105 A US 3842105A US 00331060 A US00331060 A US 00331060A US 33106073 A US33106073 A US 33106073A US 3842105 A US3842105 A US 3842105A Authority US United States Prior art keywords acid methyl acyloxy hydrogen carbon atoms Prior art date 1972-02-11 Legal status …

Patents.google.com

Santhera Announces Improved Liquidity Position

2022-06-02  · Ad hoc announcement pursuant to Art. 53 LR Restructured timing of ReveraGen milestone payments, reducing near-term liquidity needsSecured up to CHF 40 million of additional financing Pratteln ...

Au.sports.yahoo.com


Domains Expiration Date Updated

Site Provider Expiration Date
dentalassociatesoflakemary.com register.com -3 Years, -130 Days
athearnsale.com name.com -3 Years, -134 Days
sweetycoinex.com publicdomainregistry.com -3 Years, -61 Days
broadpointgroup.com godaddy.com -3 Years, -164 Days
pepebotellaphoto.com ionos.com -3 Years, -156 Days
opcrux.org whois.godaddy.com -3 Years, -99 Days
serial4you.club pananames.com -3 Years, -208 Days
sportsmensbowl.com gkg.net 1 Year, 69 Days
9889188.com 22.cn -3 Years, -277 Days
ninastemme.com 1api.net -3 Years, -335 Days

    Browser All

    .com6.5M domains   

    .org1.1M domains   

    .edu61.2K domains   

    .net746.9K domains   

    .gov23.6K domains   

    .us47.6K domains   

    .ca63K domains   

    .de612.2K domains   

    .uk489.4K domains   

    .it56.6K domains   

    .au67.9K domains   

    .co55.9K domains   

    .biz19.4K domains   

    .info48.4K domains   

    .fr57.6K domains   

    .eu40.1K domains   

    .ru265.9K domains   

    .ph8.3K domains   

    .in84.8K domains   

    .vn25.6K domains   

    .cn85.2K domains   

    .ro28.2K domains   

    .ch23K domains   

    .at18K domains   

    Browser All